The British car maker sparked widespread controversy last month when it unveiled dramatic changes ahead of becoming a fully electric brand.

Hundreds of people with a rare form of eye cancer in England will have access to a “pioneering” drug on the NHS, officials have announced. Tebentafusp – sold under the brand name Kimmtrak – is the ...